Phase III trials for new PI.
D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D002219:Carbamates; D002626:Chemistry, Pharmaceutical; D017326:Clinical Trials, Phase III as Topic; D015224:Dideoxynucleosides / Q000627:therapeutic use; D005663:Furans; D017320:HIV Protease Inhibitors / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D019888:Nelfinavir / Q000627:therapeutic use; D010755:Organophosphates; D011355:Prodrugs / Q000737:chemistry / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013449:Sulfonamides / Q000737:chemistry / Q000627:therapeutic use*; D000099227:Abacavir
D002219:Carbamates; D015224:Dideoxynucleosides; D005663:Furans; D017320:HIV Protease Inhibitors; D019259:Lamivudine; D019888:Nelfinavir; D010755:Organophosphates; D011355:Prodrugs; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir; C426859:fosamprenavir